4 ms·
It would still only be the same number of people per trial. They wouldn't have gotten trouble finding volunteers. And even if they just prioritized starting th
by handmodel 5y ago
It would still only be the same number of people per trial. They wouldn't have gotten trouble finding volunteers.
And even if they just prioritized starting the first one ASAP - they didn't do any dosage testing until after it had been released to general public for months. Even if not ideal they could have started dosage trials in November after all the data from the original was done. Instead, they waited six months before even considering this.
- belltaco 5y agoEven if you find all those multiple number of volunteers, you still need additional vaccine doses to be manufactured, which can take longer because they need more supplies from third parties, and scale up early. Not to mention all the extra staff to run the trials. If somehow they're able to run trials on 12x the volunteers, I would rather that they increase the participants by 12x for the final dose so that you get more confidence in the Phase 3 study results and in finding rare side effects.